Streamline AAV Production and Improve Performance – Download Article!

Adeno-associated viruses (AAVs) have become a prominent vector for gene therapies, favored for their safety profile, low immunogenicity, and ability to drive long-lasting transgene expression.

Are you looking to streamline AAV production and improve performance? Our white paper explores how the AAViator™ Production Platform offers one approach for improving productivity and consistency while reducing complexity. 

What you will discover in this white paper

• Key Insights: Understand the core challenges in AAV production and their impact on manufacturing processes. 
• Innovative Solution: Discover how the AAViator™ Production Platform which includes TransIT^® AAViator Transfection Reagent, ReVIT™ AAV Enhancer, with Cellvento® 4HEK medium and DMEM-high glucose can accelerate timelines and reduce costs while maintaining high product quality
• Performance Data: Review performance data demonstrating significant improvements in AAV titers and empty/full capsid ratio across multiple serotypes.

Fields with an * are required.